Trials / Completed
CompletedNCT04859660
Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy
Pre-operative Tamsulosin After Minimally Invasive Hysterectomy and Time to Spontaneous Void: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 161 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin | Participants will be given Tamsulosin or placebo in the pre-op bay prior to surgery. Post-operatively, time to void and time to discharge from the post-anesthesia care unit will be recorded. |
| DRUG | Placebo | Participants will be given Tamsulosin or placebo in the pre-op bay prior to surgery. Post-operatively, time to void and time to discharge from the post-anesthesia care unit will be recorded. |
Timeline
- Start date
- 2021-04-16
- Primary completion
- 2023-06-24
- Completion
- 2023-06-24
- First posted
- 2021-04-26
- Last updated
- 2024-02-29
- Results posted
- 2024-02-29
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04859660. Inclusion in this directory is not an endorsement.